Efficacy Comparison Between Levetiracetam and Valproic Acid in Pediatric Patients With Status Epilepticus

NACompletedINTERVENTIONAL
Enrollment

138

Participants

Timeline

Start Date

November 1, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2025

Conditions
Status Epilepticus
Interventions
DRUG

Levetiracetam

Patients were treated with intravenous levetiracetam (LEV) 20 mg/kg over 15 minutes, followed by 60 mg/kg/day in two divided doses over 24 hours.

DRUG

Valproic acid

Patients received intravenous valproic acid at 15 mg/kg over 15 minutes, followed by 20 mg/kg/day in two divided doses over 24 hours.

Trial Locations (1)

66000

Nishtar University Hospital, Multan

All Listed Sponsors
lead

RESnTEC, Institute of Research

OTHER

NCT07052136 - Efficacy Comparison Between Levetiracetam and Valproic Acid in Pediatric Patients With Status Epilepticus | Biotech Hunter | Biotech Hunter